Tierarztl Prax Ausg G Grosstiere Nutztiere 2014; 42(05): 311-317
DOI: 10.1055/s-0038-1623240
Für Studium und Praxis
Schattauer GmbH

Das equine leukämische Lymphom – eine seltene Unterart des equinen Lymphoms

Equine leukaemic lymphoma – a rare form of equine lymphoma
J. Winter
1   Klinik für Pferde, Allgemeine Chirurgie und Radiologie, Fachbereich für Veterinärmedizin der Freien Universität Berlin
,
O. Kershaw
2   Institut für Tierpathologie, Fachbereich Veterinärmedizin der Freien Universität Berlin
,
R. Schmitz
1   Klinik für Pferde, Allgemeine Chirurgie und Radiologie, Fachbereich für Veterinärmedizin der Freien Universität Berlin
,
H. Gehlen
1   Klinik für Pferde, Allgemeine Chirurgie und Radiologie, Fachbereich für Veterinärmedizin der Freien Universität Berlin
› Author Affiliations
Further Information

Publication History

Eingegangen: 03 December 2013

Akzeptiert nach Revision: 09 September 2014

Publication Date:
05 January 2018 (online)

Zusammenfassung

Das equine leukämische Lymphom ist eine selten vorkommende Erkrankung des hämatopoetischen Gewebes. Es entsteht durch neoplastische Entartung von B- und T-Lymphozyten im Lymphgewebe und deren Auftreten in der Blutbahn. Die klinischen Symptome sind häufig unspezifisch und umfassen chronischen Gewichtsverlust, Ödeme an Unterbrust und Unterbauch sowie regionale Lymphadenopathien. Häufig werden die Pferde erst spät im Krankheitsverlauf vorgestellt und die Behandlung führt selten zum Erfolg. Die Übersichtsarbeit beschreibt klinische Symptome des equinen leukämischen Lymphoms, Befunde der labordiagnostischen sowie anderer weiterführender Untersuchungen und stellt die bisher aus der Literatur bekannten Therapieansätze dar.

Summary

Equine leukaemic lymphoma is a rare disease of the haematopoetic tissue. It results from neoplastic degradation of B- and T-lymphocytes and their occurrence in the blood. Clinical signs are often unspecific and include chronic weight loss, ventral oedema at the thorax and abdomen and regional lymphadenopathy. Horses are often presented late in the course of the disease and therapy is rarely successful. This review summarizes the clinical pathologic findings of equine leukaemic lymphoma and the findings of laboratory testing and other diagnostic measures, and presents treatment options described in the literature.

 
  • Literatur

  • 1 Allen BV, Wannop CC, Wright IM. Multicentric lymphosarcoma with lymphoblastic leukaemia in a young horse. Vet Rec 1984; 115: 130-131.
  • 2 Bernard W, Sweeney C, Morris F. Primary lymphocytic leukemia in a horse. Equine Pract 1988; 10: 24-30.
  • 3 Bezdekova B, Faldyna M, Zapletal O, Jahn P. Acute B-lymphoid leukemia in a mare: a case report. Veterinari Med 2009; 54: 249-255.
  • 4 Cian F, Tyner G, Martini V, Comazi S, Archer J. Leukemic small cell lymphoma or chronic lymphocytic leukemia in a horse. Vet Clin Pathol 2013; 42: 301-306.
  • 5 Dabareiner RM, Sullins KE, Goodrich LR. Large colon resection for treatment of lymphosarcoma in two horses. J Am Vet Med Assoc 1996; 208: 895-889.
  • 6 Dascanio JJ, Zhang CH, Antczak DF, Blue JT, Simmons TR. Differentiation of chronic lymphocytic leukemia in the horse. A report of two cases. J Vet Intern Med 1992; 6: 225-229.
  • 7 de Brujn CM, Veenman JN, Rutten VP, Teske E, van Nieuwstadt RA, Ingh TS. Clinical, histopathological and immunophenotypical findings in five horses with cutaneous malignant lymphoma. Res Vet Sci 2007; 83: 63-72.
  • 8 Doyle AJ, MacDonald VS, Bourque A. Use of lomustine (CCNU) in a case of cutaneous equine lymphoma. Can Vet J 2013; 54: 1137-1141.
  • 9 Durham AC, Pilitteri CA, San Myint M, Valli VE. Two hundred three cases of equine lymphoma classified according to the World Health Organization (WHO) classification criteria. Vet Pathol 2013; 50: 86-93.
  • 10 Esplin DG, Taylor JL. Hypercalcemia in a horse with lymphosarcoma. J Am Vet Med Assoc 1977; 170: 180-182.
  • 11 Finley MR, Rebhun WC, Dee A, Langsetmo I. Paraneoplastic pruritus and alopecia in a horse with diffuse lymphoma. J Am Vet Med Assoc 1998; 213: 102-104.
  • 12 Fukunaga K, Ninomiya M, Oohara Y, Kusunose K, Okamura Y, Nagasaki H, Ishino S, Kadota K. Lymphoplasmacytic lymphoma in a stallion. J Vet Med Sci 1993; 55: 465-467.
  • 13 Garber JL, Reef VB, Reimer JM. Sonographic findings in horses with mediastinal lymphosarcoma: 13 cases (1985–1992). J Am Vet Med Assoc 1994; 205: 1432-1436.
  • 14 Gavazza A, Lubas G, Turinelli V, Ghernati I, Delgadillo AJ. A case report of T-cell lymphoma in a horse. Vet Res Comm 2003; 27 (Suppl. 01) 403-405.
  • 15 Germann SE, Richter M, Schwarzwald CC, Wimmershoff J, Spiess BM. Ocular, multicentric lymphoma in a young racehorse. Vet Ophthalmol 2008; 11 (Suppl. 01) 51-56.
  • 16 Haley PJ, Spraker T. Lymphosarcoma in an aborted equine fetus. Vet Pathol 1983; 20: 647-649.
  • 17 Harvey WH. Bone marrow examination. In: Veterinary Hematology: A Diagnostic Guide and Color Atlas. 1st ed.. Harvey WH. ed. St. Louis: Elsevier Saunders; 2012: 254-255.
  • 18 Henson F, Dixon K, Dobson J. Treatment of 4 cases of equine lymphoma with megavoltage radiation. Equine Vet Educ 2004; 16: 312-314.
  • 19 Henson KL, Alleman AR, Cutler TJ, Ginn PE, Kelley LC. Regression of subcutaneous lymphoma following removal of an ovarian granulosatheca cell tumor in a horse. J Am Vet Med Assoc 1998; 212: 1419-1422.
  • 20 Henson KL, Alleman AR, Kelley LC, Mahaffey EA. Immunohistochemical characterization of estrogen and progesterone receptors in lymphoma of horses. Vet Clin Pathol 2000; 29: 40-46.
  • 21 Hermeyer K, Seehusen F, Gehlen H, Peters M, Wohlsein P. Cutaneous T-cell- rich B-cell lymphoma in a horse. Berl Münch Tierärztl Wochenschr 2010; 123: 422-424.
  • 22 Katayama H, Takeuchi M, Yoshino T, Munemasa M. Epstein-Barr virus associated diffuse large B-cell lymphoma complicated by autoimmune hemolytic anemia and pure red cell aplasia. Leuk Lymphoma 2001; 42: 539-542.
  • 23 Koch TG, Wen X, Bienzle D. Lymphoma, erythrocytosis, and tumor erythropoietin gene expression in a horse. J Vet Intern Med 2006; 20: 1251-1255.
  • 24 Labelle P, De Cock HE. Metastatic tumors to the adrenal glands in domestic animals. Vet Pathol 2005; 42: 52-58.
  • 25 Lester GD, Allema AR, Raskin RE, Meyer JC. Pancytopenia secondary to lymphoid leukemia in three horses. J Am Vet Intern Med 1993; 7: 360-363.
  • 26 Lunn P, Horohov D. The equine immune system. In: Equine Internal Medicine. 3rd edn.. Reed SM, Warwick MB, Sellon DC. eds. St. Louis: Elsevier Saunders; 2010: 7-11.
  • 27 Mackey VS, Wheat JD. Reflections on the diagnostic approach to multicentric lymphosarcoma in an aged Arabian mare. Equine Vet J 1985; 17: 467-469.
  • 28 Mair TS, Brown PJ. Clinical and pathological features of thoracic neoplasia in the horse. Equine Vet J 1993; 25: 220-223.
  • 29 Mair TS, Yeo SP, Lucke VM. Hypercalcaemia and soft tissue mineralisation associated with lymphosarcoma in two horses. Vet Rec 1990; 126: 99-101.
  • 30 Mair TS, Couto CG. The use of cytotoxic drugs in equine practice. Equine Vet Educ 2006; 18 (03) 149-156.
  • 31 Marr CM, Love S, Pirie HM. Clinical, ultrasonographic and pathological findings in a horse with splenic lymphosarcoma and pseudohyperparathyroidism. Equine Vet J 1989; 21: 221-226.
  • 32 McClure JT. Leukoproliferative disorders in horses. Vet Clin North Am Equine Pract 2000; 16: 165-182.
  • 33 McClure JT, Young KM, Fiste M, Sharkey LC, Lunn DP. Immunophenotypic classification of leukemia in 3 horses. J Vet Intern Med 2001; 15: 144-152.
  • 34 Meyer J, Delay J, Bienzle D. Clinical, laboratory, and histopathologic features of equine lymphoma. Vet Pathol 2006; 43: 914-924.
  • 35 McGovern KF, Lascola KM, Davis E, Frederickson RL, Tan R. T-cell lymphoma with immune-mediated anemia and thrombocytopenia in a horse. J Vet Intern Med 2011; 25: 1181-1185.
  • 36 Morrison LR, Freel K, Henderson I, Hahn C, Smith SH. Lymphoproliferative disease with features of lymphoma in the central nervous system of a horse. J Comp Pathol 2008; 139: 256-261.
  • 37 Munoz A, Riber C, Trigo P, Castejon F. Hematopoietic neoplasias in horses: Myeloproliferative and lymphoproliferative disorders. J Equine Sci 2009; 20: 59-72.
  • 38 Rebhun WC, Del Piero F. Ocular lesions in horses with lymphosarcoma: 21 cases (1977–1997). J Am Vet Med Assoc 1998; 212: 852-854.
  • 39 Reef VB, Dyson SS, Beech J. Lymphosarcoma and associated immune-mediated hemolytic anemia and thrombocytopenia in horses. J Am Vet Med Assoc 1984; 184: 313-317.
  • 40 Rendle DI, Durham AE, Thompson JC, Archer J, Mitchell M, Saunders K, Millere J, Paillot R, Smith KC, Kydd JH. Clinical, immunophenotypic and functional characterisations of T-cell-leukemia in six horses. Equine Vet J 2007; 39: 522-528.
  • 41 Roberts MC. A case of primary lymphoid leukemia in a horse. Equine Vet J 1977; 9: 216-219.
  • 42 Savage CJ. Lymphoproliferative and myeloproliferative disorders. Vet Clin North Am Equine Pract 1998; 14: 563-578.
  • 43 Schalm O. Lymphosarcoma in the horse. Vet Clin North Am Equine Pract 1981; 3: 23.
  • 44 Sellon DC, Wise LN. Disorders of the hematopoietic system. In: Equine Internal Medicine. 3rd edn.. Reed SM, Warwick MB, Sellon DC. eds. St. Louis: Elsevier Saunders; 2010: 747-749.
  • 45 Taintor J, Schleis S. Equine Lymphoma. Equine Vet Educ 2011; 23: 205-213.
  • 46 Taintor J. Clinical Commentary – Equine Leukaemia. Equine Vet Educ 2012; 24: 604-609.
  • 47 Taylor SD, Pusterla N, Vaughan B, Whitcomb MB, Wilson WD. Intestinal neoplasia in horses. J Vet Intern Med 2006; 20: 1429-1436.
  • 48 Théon AP, Pusterla N, Magdesian KG, Wittenburg L, Marmulak T, Wilson WD. A pilot phase II study of the efficacy and biosafety of doxorubicin chemotherapy in tumor-bearing equidae. J Vet Intern Med 2013; 27: 1581-1588.
  • 49 Tizard IR. Systemic response to inflammation. In: Veterinary Immunology. 9th edn.. St. Louis: Elsevier; 2008: 54.
  • 50 Tomlinson MJ, Doster AR, Wright ER. Lymphosarcoma with virus-like particles in a neonatal foal. Vet Pathol 1979; 16: 629-631.
  • 51 Valli VE, San Myint M, Barthel A., Bienzle D, Caswell J, Colbatzky F, Durham A, Ehrhart EJ, Johnson Y, Jones C, Kiupel M, Labelle P, Lester S, Miller M, Moore P, Moroff S, Roccabianca P, Ramos-Vara J, Ross A, Scase T, Tvedten H, Vernau W. Classification of canine malignant lymphomas according to the World Health Organization criteria. Vet Pathol 2011; 48: 198-211.
  • 52 Walenta S, Schroeder T, Mueller-Klieser W. Lactate in solid malignant tumors: Potential basis of a metabolic classification in clinical oncology. Curr Med Chem 2004; 11: 2195-2204.
  • 53 Zicker SC, Wilson WD, Medearis I. Differentiation between intra-abdominal neoplasms and abscesses in horses, using clinical and laboratory data: 40 cases (1973–1988). J Am Vet Assoc 1990; 196: 1130-1134.